共 44 条
[1]
Shanmugam VK(2012)Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management Curr Opin Rheumatol 24 669-676
[2]
Steen VD(2017)Points to consider in renal involvement in systemic sclerosis Rheumatology (Oxford) 56 v49-v52
[3]
Galluccio F(2016)Scleroderma renal crisis and renal involvement in systemic sclerosis Nat Rev Nephrol 12 678-691
[4]
Muller-Ladner U(2019)Pathogenesis and therapeutic interventions for anca-associated vasculitis Nat Rev Rheumatol 15 91-101
[5]
Furst DE(2016)Anca-associated glomerulonephritis: risk factors for renal relapse PLoS ONE 11 e165402-2350
[6]
Woodworth TG(2017)The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in olmsted county, minnesota: a twenty-year us population-based study Arthritis Rheumatol 69 2338-180
[7]
Suliman YA(2002)Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature Joint Bone Spine 69 177-689
[8]
Li W(2018)Prognostic factors of renal involvement in systemic sclerosis Kidney Blood Press Res 43 682-106
[9]
Nakazawa D(2019)Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity Clin Rheumatol 38 97-9
[10]
Masuda S(2019)Patients with anca-associated glomerulonephritis and connective tissue diseases: a comparative study from the maine-anjou aav registry J Clin Med 8 1218-229